Reforgene Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 23

Reforgene General Information

Description

Developer of gene-editing therapeutics designed to treat genetic and serious diseases through genome engineering. The company offers gene-editing platforms, CRISPR-based technologies, and drug development capabilities, enabling healthcare providers and patients to access curative therapies for complex and inherited disorders.

Contact Information

Website
www.reforgene.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 50101, Building A4, Number 1 & 3 Qinghui Middle Road
  • Number 1 Chuangzhi Third Street, Nansha District
  • Guangzhou, Guangdong 510000
  • China
+86 020
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Room 50101, Building A4, Number 1 & 3 Qinghui Middle Road
  • Number 1 Chuangzhi Third Street, Nansha District
  • Guangzhou, Guangdong 510000
  • China
+86 020

Reforgene Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reforgene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 30-Dec-2024 Completed Generating Revenue
5. Early Stage VC 11-Apr-2023 Completed Generating Revenue
4. Secondary Transaction - Private 12-Jan-2023 Completed Generating Revenue
3. Early Stage VC (Series A1) 13-Sep-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 02-Nov-2020 $14.9M $14.9M Completed Generating Revenue
1. Early Stage VC 19-Jan-2020 Completed Generating Revenue
To view Reforgene’s complete valuation and funding history, request access »

Reforgene Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 13

    Pending

  • Expiring in next 12 mo

Reforgene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026214717-A1 Novel crispr/cas system and use thereof Pending 10-Apr-2025
WO-2026175368-A1 Iscb protein and use thereof Pending 18-Feb-2025
WO-2026061453-A1 Targeting system and use thereof Pending 18-Sep-2024
WO-2026016730-A1 Mutant hla-e heavy chain, hla-e trimer, and use thereof Pending 17-Jul-2024
EP-4737566-A1 Cas12 protein and use thereof Pending 24-May-2024 C12N15/907
To view Reforgene’s complete patent history, request access »

Reforgene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reforgene Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Guangzhou Financial Holdings Corporation Minority
Guangzhou Industrial Investment Holding Group Government Minority
Guangzhou Jinkong Fund Asset Manager Minority
Guangzhou Science and Technology Financial Innovation Investment Holding Venture Capital Minority
Jingjinji National Center of Technology Innovation Growth/Expansion Minority
You’re viewing 5 of 23 investors. Get the full list »

Ready to get started?

Request a free trial

Reforgene FAQs

  • When was Reforgene founded?

    Reforgene was founded in 2019.

  • Where is Reforgene headquartered?

    Reforgene is headquartered in Guangzhou, China.

  • What is the size of Reforgene?

    Reforgene has 8 total employees.

  • What industry is Reforgene in?

    Reforgene’s primary industry is Discovery Tools (Healthcare).

  • Is Reforgene a private or public company?

    Reforgene is a Private company.

  • What is Reforgene’s current revenue?

    The current revenue for Reforgene is .

  • How much funding has Reforgene raised over time?

    Reforgene has raised $44.9M.

  • Who are Reforgene’s investors?

    Guangzhou Financial Holdings, Guangzhou Industrial Investment Holding Group, Guangzhou Jinkong Fund, Guangzhou Science and Technology Financial Innovation Investment Holding, and Jingjinji National Center of Technology Innovation are 5 of 23 investors who have invested in Reforgene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process